Wang YL - Search Results

1

Functional significance of myocardial activity at ¹⁸F-FAPI PET/CT in hypertrophic cardiomyopathy identified by cardiac magnetic resonance feature-tracking strain analysis.

Zhang Y, Dong Z, Wang L, Wang YL, Chen BX, Su Y, Zhao S, Yang MF. Zhang Y, et al. Among authors: wang l, wang yl. Eur J Nucl Med Mol Imaging. 2023 Dec;51(1):110-122. doi: 10.1007/s00259-023-06411-0. Epub 2023 Aug 29. Eur J Nucl Med Mol Imaging. 2023. PMID: 37642705

2

MiR-451 is decreased in hypertrophic cardiomyopathy and regulates autophagy by targeting TSC1.

Song L, Su M, Wang S, Zou Y, Wang X, Wang Y, Cui H, Zhao P, Hui R, Wang J. Song L, et al. J Cell Mol Med. 2014 Nov;18(11):2266-74. doi: 10.1111/jcmm.12380. Epub 2014 Sep 11. J Cell Mol Med. 2014. PMID: 25209900 Free PMC article.

3

Cardiac fibroblast activation imaging in a patient with hypertrophic cardiomyopathy.

Zhang Y, Wang YL, Yang MF, Wang L. Zhang Y, et al. Among authors: wang l, wang yl. J Nucl Cardiol. 2023 Aug;30(4):1697-1699. doi: 10.1007/s12350-022-02967-w. Epub 2022 Apr 12. J Nucl Cardiol. 2023. PMID: 35415823 No abstract available.

4

Myocardial Activity at ¹⁸F-FAPI PET/CT and Risk for Sudden Cardiac Death in Hypertrophic Cardiomyopathy.

Wang L, Wang Y, Wang J, Xiao M, Xi XY, Chen BX, Su Y, Zhang Y, Xie B, Dong Z, Zhao S, Yang MF. Wang L, et al. Radiology. 2023 Feb;306(2):e221052. doi: 10.1148/radiol.221052. Epub 2022 Oct 11. Radiology. 2023. PMID: 36219116

5

Cardiac fibroblast activation in Fabry disease on ¹⁸F-fibroblast activation protein inhibitor positron emission tomography/computed tomography imaging.

Wang YL, Wang L, Dong Z, Yang MF. Wang YL, et al. Among authors: wang l. Eur Heart J Case Rep. 2022 Oct 18;6(11):ytac419. doi: 10.1093/ehjcr/ytac419. eCollection 2022 Nov. Eur Heart J Case Rep. 2022. PMID: 36339458 Free PMC article. No abstract available.

6

[No title available]

[No authors listed] [No authors listed] PMID: 38245302

7

Multiple gene mutations, not the type of mutation, are the modifier of left ventricle hypertrophy in patients with hypertrophic cardiomyopathy.

Zou Y, Wang J, Liu X, Wang Y, Chen Y, Sun K, Gao S, Zhang C, Wang Z, Zhang Y, Feng X, Song Y, Wu Y, Zhang H, Jia L, Wang H, Wang D, Yan C, Lu M, Zhou X, Song L, Hui R. Zou Y, et al. Mol Biol Rep. 2013 Jun;40(6):3969-76. doi: 10.1007/s11033-012-2474-2. Epub 2013 Jan 3. Mol Biol Rep. 2013. PMID: 23283745

8

Clinical profile and prognostic significance of atrial fibrillation in hypertrophic cardiomyopathy.

Tian T, Wang Y, Sun K, Wang J, Zou Y, Zhang W, Bao J, Zhu L, Shen H, Hui R, Zhou X, Song L. Tian T, et al. Cardiology. 2013;126(4):258-64. doi: 10.1159/000354953. Epub 2013 Oct 23. Cardiology. 2013. PMID: 24157592

9

Myocardial bridging as a common phenotype of hypertrophic cardiomyopathy has no effect on prognosis.

Tian T, Wang YL, Wang JZ, Sun K, Zou YB, Zhang WL, Zhu L, Shen H, Hui RT, Zhou XL, Song L. Tian T, et al. Among authors: wang jz, wang yl. Am J Med Sci. 2014 Jun;347(6):429-33. doi: 10.1097/MAJ.0000000000000194. Am J Med Sci. 2014. PMID: 24270076

10

Rare variants in genes encoding MuRF1 and MuRF2 are modifiers of hypertrophic cardiomyopathy.

Su M, Wang J, Kang L, Wang Y, Zou Y, Feng X, Wang D, Ahmad F, Zhou X, Hui R, Song L. Su M, et al. Int J Mol Sci. 2014 May 26;15(6):9302-13. doi: 10.3390/ijms15069302. Int J Mol Sci. 2014. PMID: 24865491 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,558 results

Search Page

Filters